Tides 速递 | 歌礼制药将公布多项肥胖项目研究成果

多肽圈
Oct 29, 2025

|中肽生化内容团队编辑2025年10月27日,歌礼制药有限公司(香港联交所代码:1672,简称“歌礼”)宣布将在美国佐治亚州亚特兰大举行的2025年肥胖周(ObesityWeek®)以壁报形式报告多款肥胖症候选药物,包括ASC30以及ASC31与ASC47联合疗法。此次展示的重点包括:- ASC30:口服GLP-1受体小分子激动剂的28天多次递增剂量研究完整分析(被列为Late-breaking ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10